Clinical Trial Update: Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis [Phase 3]

View source ↗

Summary

Phase 3 comparative trial of empagliflozin versus pioglitazone in non-diabetic patients with non-alcoholic steatohepatitis (NASH) is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Empagliflozin (empagliflozin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Tanta University | Conditions: Non Alcoholic Steatohepatitis | Phase 3 | Status: UNKNOWN